Cargando…

An efficient system to generate monoclonal antibodies against membrane-associated proteins by immunisation with antigen-expressing mammalian cells

BACKGROUND: The generation of monoclonal antibodies specific for protein antigens usually depends on purified recombinant protein for both immunisation and hybridoma screening. Purification of recombinant protein in sufficient yield and purity is a tedious undertaking and can be demanding especially...

Descripción completa

Detalles Bibliográficos
Autores principales: Dreyer, Anita M, Beauchamp, Jeremy, Matile, Hugues, Pluschke, Gerd
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019159/
https://www.ncbi.nlm.nih.gov/pubmed/21159168
http://dx.doi.org/10.1186/1472-6750-10-87
_version_ 1782196173261504512
author Dreyer, Anita M
Beauchamp, Jeremy
Matile, Hugues
Pluschke, Gerd
author_facet Dreyer, Anita M
Beauchamp, Jeremy
Matile, Hugues
Pluschke, Gerd
author_sort Dreyer, Anita M
collection PubMed
description BACKGROUND: The generation of monoclonal antibodies specific for protein antigens usually depends on purified recombinant protein for both immunisation and hybridoma screening. Purification of recombinant protein in sufficient yield and purity is a tedious undertaking and can be demanding especially in the case of membrane proteins. Furthermore, antibodies generated against a purified recombinant protein are frequently incapable of binding to the endogenous protein in its native context. RESULTS: We describe a strategy to generate monoclonal antibodies against membrane or membrane-associated proteins that completely bypasses any need for purified recombinant antigen. This approach utilises stably transfected mammalian cells expressing recombinant antigens on their cell surface for immunisation of mice. The transfected cells are also used for measuring seroconversion, hybridoma selection and antibody characterisation. By presenting the antigen in its native conformation for immunisation and hybridoma selection, this procedure promotes the generation of antibodies capable of binding to the endogenous protein. In the present study, we applied this approach successfully for three predicted GPI-anchored proteins of the malaria parasite Plasmodium falciparum. CONCLUSIONS: The described entirely cell-based technology is a fast and efficient approach for obtaining antibodies reactive with endogenous cell-surface proteins in their native conformation.
format Text
id pubmed-3019159
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30191592011-01-12 An efficient system to generate monoclonal antibodies against membrane-associated proteins by immunisation with antigen-expressing mammalian cells Dreyer, Anita M Beauchamp, Jeremy Matile, Hugues Pluschke, Gerd BMC Biotechnol Research Article BACKGROUND: The generation of monoclonal antibodies specific for protein antigens usually depends on purified recombinant protein for both immunisation and hybridoma screening. Purification of recombinant protein in sufficient yield and purity is a tedious undertaking and can be demanding especially in the case of membrane proteins. Furthermore, antibodies generated against a purified recombinant protein are frequently incapable of binding to the endogenous protein in its native context. RESULTS: We describe a strategy to generate monoclonal antibodies against membrane or membrane-associated proteins that completely bypasses any need for purified recombinant antigen. This approach utilises stably transfected mammalian cells expressing recombinant antigens on their cell surface for immunisation of mice. The transfected cells are also used for measuring seroconversion, hybridoma selection and antibody characterisation. By presenting the antigen in its native conformation for immunisation and hybridoma selection, this procedure promotes the generation of antibodies capable of binding to the endogenous protein. In the present study, we applied this approach successfully for three predicted GPI-anchored proteins of the malaria parasite Plasmodium falciparum. CONCLUSIONS: The described entirely cell-based technology is a fast and efficient approach for obtaining antibodies reactive with endogenous cell-surface proteins in their native conformation. BioMed Central 2010-12-15 /pmc/articles/PMC3019159/ /pubmed/21159168 http://dx.doi.org/10.1186/1472-6750-10-87 Text en Copyright ©2010 Dreyer et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Dreyer, Anita M
Beauchamp, Jeremy
Matile, Hugues
Pluschke, Gerd
An efficient system to generate monoclonal antibodies against membrane-associated proteins by immunisation with antigen-expressing mammalian cells
title An efficient system to generate monoclonal antibodies against membrane-associated proteins by immunisation with antigen-expressing mammalian cells
title_full An efficient system to generate monoclonal antibodies against membrane-associated proteins by immunisation with antigen-expressing mammalian cells
title_fullStr An efficient system to generate monoclonal antibodies against membrane-associated proteins by immunisation with antigen-expressing mammalian cells
title_full_unstemmed An efficient system to generate monoclonal antibodies against membrane-associated proteins by immunisation with antigen-expressing mammalian cells
title_short An efficient system to generate monoclonal antibodies against membrane-associated proteins by immunisation with antigen-expressing mammalian cells
title_sort efficient system to generate monoclonal antibodies against membrane-associated proteins by immunisation with antigen-expressing mammalian cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019159/
https://www.ncbi.nlm.nih.gov/pubmed/21159168
http://dx.doi.org/10.1186/1472-6750-10-87
work_keys_str_mv AT dreyeranitam anefficientsystemtogeneratemonoclonalantibodiesagainstmembraneassociatedproteinsbyimmunisationwithantigenexpressingmammaliancells
AT beauchampjeremy anefficientsystemtogeneratemonoclonalantibodiesagainstmembraneassociatedproteinsbyimmunisationwithantigenexpressingmammaliancells
AT matilehugues anefficientsystemtogeneratemonoclonalantibodiesagainstmembraneassociatedproteinsbyimmunisationwithantigenexpressingmammaliancells
AT pluschkegerd anefficientsystemtogeneratemonoclonalantibodiesagainstmembraneassociatedproteinsbyimmunisationwithantigenexpressingmammaliancells
AT dreyeranitam efficientsystemtogeneratemonoclonalantibodiesagainstmembraneassociatedproteinsbyimmunisationwithantigenexpressingmammaliancells
AT beauchampjeremy efficientsystemtogeneratemonoclonalantibodiesagainstmembraneassociatedproteinsbyimmunisationwithantigenexpressingmammaliancells
AT matilehugues efficientsystemtogeneratemonoclonalantibodiesagainstmembraneassociatedproteinsbyimmunisationwithantigenexpressingmammaliancells
AT pluschkegerd efficientsystemtogeneratemonoclonalantibodiesagainstmembraneassociatedproteinsbyimmunisationwithantigenexpressingmammaliancells